Increasing out-of-pocket healthcare expenditure and patent expiries of blockbuster drugs fuelling the global branded generics market

A recent research conducted by Future Market Insights predicts that the global market for branded generics will witness a steady growth in terms of revenues. Over a ten-year forecast period from 2016 to 2026, the size of global branded generics market has been estimated to expand at a steady CAGR of 7.3%. Brand-name prescriptions will continue to be ubiquitous among aged people in the world, and since geriatric demographics account for a large portion of global drug-consuming population, demand for branded generics will also rise substantially. In 2016, the global branded generics market has been valued at nearly US$ 200 billion, and is projected to reach US$ 413.8 Bn market valueby the end of forecast period.

A sample of this report is available upon request @  https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Some of the leading manufacturers of branded generics are based in Asian countries, and are extending their production capacity to keep up with the surging global depend. In Asia-Pacific excluding Japan (APEJ) region, about US$ 150 billion revenues are expected to be procured by the end of 2026. During the forecast period, branded generics market in the APEJ region will attain fastest growth, registering a 10% CAGR, contributing over 35% of global branded generics revenues. North America, Eastern Europe and Latin America are also expected to be lucrative for growth of branded generics sales, while revenues in Western Europe, Japan and Middle East & Africa (MEA) are likely to incur a considerable dip by 2026-end.

Competitive Timeline in Global Branded Generics Market

• Since 2015, Abbott Laboratories, a leading drugmaker in the global pharmaceuticals industry, has aimed at capitalizing from branded generics businesses in developing regions.
• Teva Pharmaceuticals acquired Allergan’s branded generics vertical, while Pfizer Inc. bought Hospira Inc. – both acquisitions have been strategically carried out for repositioning market standings of Teva and Pfizer respectively.
• In December 2016, India-based Sun Pharmaceuticals Industries Ltd. agreed to buy Swiss drugmaker Novartis AG’s branded generics portfolio on cancer medications.
• Another leading branded generics manufacturer, Mylan N.V. recently launched anti-allergy devices which are expected to be half the price of its branded EpiPens.
• Other prominent companies partaking in the growth of global branded generics market include, Aspen Pharmacare Holding Ltd. and Valeant Pharmaceuticals International, Inc.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-1260

Research Highlights on Global Branded Generics Market

The report includes a segmental analysis of the global branded generics market, fragmenting its growth on the type of drug formulation, major drug classes, therapeutic applications, and distribution channels. Based on such segmentation, some of the key findings compiled in the report are:

• Nearly three-fifth of the global branded generics revenues estimated in 2016 are expected to be accounted by oral-type formulations, with parenteral, topic and other formulation types collectively accounting for 8% market value share.
• Hospital pharmacies & retail pharmacies will remain as the largest distribution channels for branded generics throughout the globe.
• In 2016 and beyond, the demand for branded generics in therapeutic treatment of cardiovascular diseases will be significant, revenues from which are expected to increase at more than 8% CAGR over the forecast period.
• Global revenues of branded generics accounted by anti-hypertensive drug class are predicted to surpass US$ 25 billion by 2026-end.

Bone Growth Stimulators Market will reach at a CAGR of 9.5% from 2015 to 2025

According to the latest market report published by Future Market Insights titled, “Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025”, the bone growth stimulators market is anticipated to expand at a CAGR of 9.5% during the forecast period.

Bone growth stimulators are used in cases of delay or failure of fracture healing as they enhance the bone healing process without the sensation of electrical shocks or currents or vibrations when worn by the user. An internal bone growth stimulator or invasive bone growth stimulator is implanted on the fusion site of the bone and it delivers small electrical currents. The internal bone growth stimulator is removed from the body after 6-12 months. External bone growth stimulator or non-invasive bone growth stimulators are externally worn portable devices and do not require surgical implantation. An external bone growth stimulator is prescribed for use for two to nine hours every day for a period of around three to nine months.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-828

Economic factors such as improvement in service sector, increase in personal income, and increase in per capita healthcare expenditure are expected to drive market growth globally. Captivating product features, expanding application in the sports medicine industry, high disability cost payments, among others, are fuelling growth of the global bone growth stimulators market. However, various factors such as availability of alternative therapies, uncertainty about efficacy, device-related issues and competition from bone grafts restraint growth of the bone growth stimulators market.

By product, the global bone growth stimulators market is segmented into invasive bone growth stimulators, non-invasive bone growth stimulators and ultrasound bone growth stimulators. The non-invasive bone growth stimulators product segment-which comprises capacitive coupling devices, combined magnetic field devices and pulsed ultrasound magnetic field devices-accounts for the highest market share currently and is expected to remain the leading segment in terms of value during the forecast period. In terms of application segmentation, trauma injury and fractures segment is expected to expand at the highest CAGR in terms of value and volume over the forecast period as compared to other applications. Hospitals end user segment, though projected to account for the highest share in market, is expected to expand at an average CAGR in terms of value and volume over the forecast period. Orthopedic clinics and home care end user segments are expected to represent significant market attractiveness indices over the forecast period.

By region, North America is expected to remain the market leader in the bone growth stimulators market mainly due to consumer awareness about chronic pain related to bone fracture and injury and subsequent disability costs. Western Europe is the second-largest contributor to the global market in terms of value and volume owing to availability of public health systems and subsidies coupled with reliance of patients on the Internet to research about new technologies, such as bone growth stimulators. MEA is projected to expand at a significant pace mainly due to large (particularly expatriate) population, improvements in life expectancy and decline in mortality rates, combined with increased budgetary spend on healthcare, resulting in a major shift and boost in growth of the bone growth stimulators market in the MEA countries. The MEA bone growth stimulators market is still untapped, so companies have substantial growth opportunities in this region.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-828

Key market players covered in this report are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc. and IGEA S.p.A. Major players in the bone growth stimulators market are focusing on enhancing their global and regional presence through strategic mergers & acquisitions and operational expansion.

Urinary Tract Infection Treatment Market to Grow at a CAGR of 2.1% through 2026

Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract infections. 

Prevalence of urinary tract infections is higher in females as compared to males, with biologic and behavioural factors accounting for the major causes. Development of this ailment due to genetic causes or urogenital surgery and Estrogen deficiency was minimal.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1340  

FMI’s survey also found that prevalence of uncomplicated URI was significantly higher than complicated-, recurring complicated UTIs. However, prevalence of complicated UTI is expected to increase in the future, owing to increase in drug-resistant bacteria and excessive use of antibiotics.

The global urinary tract infection treatment market is expected to reach US$ 9.42 Bn in revenues. Complex regulatory requirements and low investment in research and development are some of the key factors for sluggish growth of the market. Clinical trials for designing antibacterial drugs are quite complex, owing to which a number of major companies have decreased their R&D spending on the development of new drugs. Moreover, UTI are not chronic like blood pressure or heart diseases and patients are symptom-free usually within 1-2 weeks of treatment, resulting into limited sales of the drugs. In addition to these factors, economic and regulatory hurdles are also restraining the growth of the urinary tract infection treatment market.

By drug type, quinolones account for the highest revenue share of the global urinary tract infection treatment market. This segment is expected to account for nearly 37.2% share of the global urinary tract infection treatment market revenues in 2016. This represents a market value of nearly US$ 3.5 Bn, up from US$ 3.43 Bn in 2015. Among quinolones, levofloxacin is the most sought-after drug type, representing nearly US$ 1.59 Bn in revenues in 2015. Penicillin and combinations is the second largest drug type, and is expected to total US$ 1.87 Bn in revenues.

Retail pharmacies will continue to remain the largest segment in terms of distribution channel in 2016. This segment accounts for nearly 56.8% revenue share, representing a market value of US$ 5.35 Bn. Gynaecology and urology clinics collectively is the second largest segment by distribution channel.

By disease indication, uncomplicated UTI will continue to dominate global revenues. This segment currently accounts for a revenue share of 52.7%, representing a market value of US$ 4.96 Bn in 2016. Neurogenic bladder infections, the second-largest segment by disease indication, is expected to increase by 2.30% in 2016.

Asia Pacific excluding Japan (APEJ) will continue to be the leading market for urinary tract infections, with total revenues expected to reach US$ 3.46 Bn in 2016. Western Europe and North America will remain the second and third largest markets respectively.

Key players operating in the urinary tract infection treatment market include Johnson & Johnson, Boehringer Ingelheim, Cipla Ltd., Bayer AG, GSK, Roche Ltd., Pfizer Inc., Novartis AG, and AstraZeneca plc. The key strategy of a majority of these key players is to expand in emerging markets and achieving inorganic growth through mergers and acquisitions.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-1340

Long-term Outlook: The global urinary tract infection treatment market is anticipated to increase at a CAGR of 2.1% during the forecast period 2016-2026 and reach US$ 11.58 Bn in revenues.

Ophthalmic Diagnostic Equipment Market Estimated to Exhibit 5.4% CAGR through 2025

According to the latest market report published by Future Market Insights, titled “Ophthalmic Diagnostic Equipment Market: Global Industry Analysis and Opportunity Assessment 2015-2025”, the ophthalmic diagnostic equipment market is expected to be valued at US$ 2,168.0 Mn by the end of 2015. It is anticipated to expand at a CAGR of 5.4% during the forecast period (2015-2025) to account for US$ 3,656.0 Mn by 2025.

Ophthalmic devices are medical devices used to identify ocular defects or deficiencies and treat eye disorders. As a result of the constant developments in ophthalmic technology for effective treatment of eye diseases and restoration of vision, more and more number of people are opting for ophthalmic surgeries to rectify their eye-related disorders. As per the World Health Organization (WHO) 2010 estimates, there were 285 Mn visually impaired people across the globe in 2010, which included 39 Mn blind people, of whom around 80% were above the age of 50 years. Ophthalmology is the branch of medical science that deals with anatomy, physiology, and disease of the eye. There are various diagnostic equipment that are used to diagnose a wide range of ophthalmic conditions and provide vision solution. These equipment are simple to use for healthcare professionals.

A sample of this report is available upon request @  https://www.futuremarketinsights.com/reports/sample/rep-gb-771

Increasing prevalence of eye-related disorders such as macular degeneration and diabetic retinopathy, rise in aging population and increasing government initiatives towards the development of healthcare infrastructure in the developing countries are the key factors driving growth of the global ophthalmic devices market currently. 

In addition, increasing prevalence of lifestyle associated diseases, such as diabetes and high blood pressure, is fuelling growth of the market further. In case of the geriatric population, treatment of eye diseases calls for more effective ophthalmology devices. Several government associations across the globe are also focused on increasing consumer awareness about ophthalmic diseases. However, various factors, such as lack of awareness about eye diseases and high risks associated with eye surgeries, act as restraints for growth of the ophthalmology devices market. Also, there are some problems associated with the use of ophthalmology devices; for instance, changes made to the cornea cannot be reversed after LASIK surgery.

By region, North America dominated the ophthalmic diagnostic equipment market with over 31.1% value share in 2014 and is expected to remain dominant throughout the forecast period. The ophthalmic diagnostic equipment market in Asia and Latin America is expected to expand at a CAGR of 5.9% and 5.7%, respectively, in terms of value, during the forecast period. Meanwhile, the Optical Coherence Tomography (OCT) product segment is expected to account for the maximum value share of the overall market during the forecast period.

Dearth of ophthalmologists and lack of associations capable of understanding the needs of the ophthalmologists are among the major factors restraining growth of the ophthalmic diagnostic equipment market currently. Meanwhile, factors such as launch of advanced technologies, product innovation, new patent approvals and research institutes and universities play a major role in driving the market growth.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-771

Key market players covered in this report are TOPCON CORPORATION, Carl Zeiss Vision International GmbH, Ellex, Quantel Medical Inc, NIDEK CO., LTD, HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc. and Kowa Company Ltd. Major players in the ophthalmic diagnostic equipment market focus on enhancing their global and regional presence through strategic acquisitions and mergers, and operational expansion.

Neonatal Thermoregulation Market will Register a CAGR of 5.0% through 2027

Future Market Insights presents a new report titled ‘Neonatal Thermoregulation Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ that studies the performance of the global neonatal thermoregulation market over a 10 year assessment period from 2017 to 2027. The report presents the value forecasts of the global neonatal thermoregulation market and provides pertinent insights into the various factors driving market growth as well as the factors restricting market growth. As per the assessment of Future Market Insights, the global neonatal thermoregulation market was estimated to be valued at nearly US$ 500 Mn in 2017 and is expected to reach a valuation of about US$ 800 Mn by 2027, and in the process exhibit a CAGR of 5.0% during the period of forecast 2017-2027.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5881  

International Companies Targeting Emerging Economies for Lucrative Opportunities in the Neonatal Thermoregulation Market

The companies involved in the manufacturing and marketing of neonatal care equipment are shifting their focus towards emerging economies such as China, India, South Africa, Brazil and Mexico. Multinational companies are especially targeting the Asian markets for developing neonatal infant care equipment due to a significant demand and a potentially large customer base. For instance, in 2013, Koninklijke Philips N.V. entered the mother and childcare business segment, where it manufactures infant warms and incubators at affordable prices as compared to other market players in India. In December 2013, the GE Healthcare designed models to improve quality of neonatal care. The company launched two products for neonatal care in India, the new Lullaby Warmer Prime, and Lullaby Resus. The cost was about 40% lower than the existing offerings from GE, so that the products are easily accessible in low-middle income economic countries. Companies in the Asia Pacific region are developing innovative solutions to meet the growing needs of the neonatal care and treatment market. Companies, such as MTTS Asia and Pluss Advanced Technologies Pvt. Ltd. have developed innovative products, such as Miracradle and MTTS Firefly, catering to the demand for cooling systems in the region.

Global Neonatal Thermoregulation Market: Segmentation and Forecast

The global neonatal thermoregulation market is segmented on the basis of product type, modality, end user and geography.

• By product type, the neonatal incubators segment was estimated to be valued at nearly US$ 250 Mn in 2017 and is likely to reach a valuation of nearly US$ 410 Mn in 2027, exhibiting a CAGR of 5.2% during the period of assessment 2017-2027.
• By modality, the closed segment was estimated to be valued at nearly US$ 270 Mn in 2017 and is anticipated to witness a CAGR of 4.7% during the period of forecast.
• By end user, the hospitals segment is expected to reach a valuation of nearly US$ 430 Mn in 2027.
• By geography, the Asia Pacific neonatal thermoregulation market was estimated to be valued at nearly US$ 170 Mn in 2017 and is likely to reach a valuation of about US$ 295 Mn in 2027, exhibiting a CAGR of 5.5% during the period of forecast.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-5881

Global Neonatal Thermoregulation Market: Competitive Landscape

In this report, some of the important companies functioning in the global neonatal thermoregulation market have been profiled in the competitive landscape section. Some of the prominent companies that have been featured include GE Healthcare, Natus Medical Incorporated., Inspiration Healthcare Group plc, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltda, Novos Medical Systems, Pluss Advanced Technologies Pvt. Ltd., Weyer GmbH, BabyBloom Healthcare BV and Medical Technology Transfer and Services Asia.

Amino Acid Metabolism Disorders Treatment Market to expand at a steady CAGR of 6.4% by 2026

 The global amino acid metabolism disorders treatment market is expected to exhibit a strong growth over the course of the forecast period. The report on global amino acid metabolism disorders treatment market has been minutely studied and researched upon by the analysts of Future Market Insights (FMI). The market research report presents an all-inclusive analysis of the global amino acid metabolism disorders treatment market along with an outline of the competition existing among the core players operating in the market. The vendor landscape section includes several facets pertaining to key players such as innovation and developments, product portfolio,  core strategies, geographical area covered, prime personnel, mergers, acquisitions, agreements, and other financial and non-financial strategies.

According to Future Market Insights, the global amino acid metabolism disorders treatment market is expected to rise at a CAGR of 6.4% from 2017 to 2026. The market is projected to touch a valuation of over US$1,030 Mn by the end of the forecast period.

A sample of this report is available upon request @  https://www.futuremarketinsights.com/reports/sample/rep-gb-6359

Key Insights on Amino Acid Metabolism Disorders Treatment Market

On the basis of region, the global amino acid metabolism disorders treatment market has been segmented into North America, Europe, Latin America, Asia Pacific except Japan, Japan, and the Middle East and Africa. Amongst these, North America is expected to retain a leading position in the market by the end of the forecast period reaching a valuation of over US$359 Mn. North America is expected to be closely followed by Europe. Players operating in this market can seek potential opportunities from the U.S., Germany, Spain, and France owing to several clinical trials taking place pertaining to this treatment and several mergers and acquisitions occurring among core players operating in these regions. Players can also find lucrative opportunities from Asia Pacific excluding Japan and as well with the rise in nutritional management activities in these regions. Countries in APAC such as China and India are also expected to emerge as potential adopters of amino acid metabolism disorders treatment in the long run.

In terms of product type, the global amino acid metabolism disorder treatment market has been segmented into arginine, folic acid, vitamin B6 and B12, thiamine, vitamin D, betaine, carglumic acid, sapropterin dihydrocholoride, and others. Among these, carglumic acid is expected to lead the market until the end of the forecast period reaching a valuation of over US$185 Mn. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate over the course of the forecast period.

Based on indication, the global market for amino acid metabolism disorder treatment has been classified into phenylketonuria, maple syrup urine disease, argininosuccinic acidemia, citrullinemia, and homocystinuria. Among all of these, phenylketonuria is expected to emerge dominant by the end of the forecast period.

On the basis of sales channel, the global market for amino acid metabolism disorder treatment has been classified into hospital pharmacies, retail pharmacies, and online sales. Hospital pharmacies is expected to take the lead among all these by the end of the forecast period.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-6359

Vendor Landscape

The companies operating in the market are Pfizer, Inc., GlaxoSmithKline PLC, Merck KGaA, Koninklijke DSM N.V., Recordati S.p.A., Sanofi, Civentichem, LLC, Shine Star (Hubei) Biological Engineering Co., Ltd., AMINO GmbH, and Kyowa Hakko Kirin Co., Ltd.

Refrigeration and Air Conditioning Compressors Market to Showcase Healthy Expansion at 4.1% CAGR During 2018-2028

Future Market Insights delivers key insights on the global refrigeration and air conditioning compressors market in its latest report titled ‘Refrigeration and Air Conditioning Compressors Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2028’. The long-term outlook of the global refrigeration and air conditioning compressors market remains positive with the market value expected to increase at a CAGR of 4.1% during the forecast period (2018 – 2028). Among product type segments, the centrifugal segment is expected to expand at a significant CAGR in terms of value over the forecast period. Among refrigerant segments, the R407C segment is anticipated to witness a high CAGR in terms of value over the forecast period. The residential segment is expected to hold a major share in terms of value among the application segments in the global refrigeration and air conditioning compressors market, owing to the growing demand for household appliances, supported by the surging population and urbanization. The global market of refrigeration and air conditioning compressors is estimated to be valued at US$ 15,333.5 Mn by the end of 2018, witnessing a Y-o-Y growth rate of 4.1% over the forecast period. China is estimated to account for a value share of 43.7% in the global refrigeration and air conditioning compressors market by 2018 end and is anticipated to remain dominant throughout the forecast period.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7040

The refrigeration and air conditioning compressors market has been experiencing significant growth for years now, particularly in China and India. Growing demand for refrigerators, display cases and air conditioners in developing countries is contributing to the substantial demand for refrigeration and air conditioning compressors in these regions.
However, the global refrigeration and air conditioning compressors market is expected to face certain challenges. The manufacturing of refrigeration and air conditioning compressors is technology-intensive as well as capital-intensive. Technology-intensive characteristics thereof reflect in precision manufacturing, which requires expensive precision processing equipment as well as a high level of management and production, continuously accumulated know-how in a relatively long period as well as continuous improvement in quality and reliability of compressors. The aforementioned reasons are expected to restrain the growth of the global refrigeration and air conditioning compressors market.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/askus/rep-gb-7040

Introduction of sustainable compressors for commercial refrigeration application is a key trend identified in the global refrigeration and air conditioning compressors market across the globe.
Segmentation Analysis

• On the basis of product type, the reciprocating segment is anticipated to dominate refrigeration and air conditioning compressors production over the forecast period
  
• On the basis of application, the residential segment is expected to register moderate growth in terms of value over the forecast period in the global refrigeration and air conditioning compressors market
  
• On the basis of refrigeration, the others segment is anticipated to dominate the market in terms of value. This segment accounted for a 27.3% value share of the global refrigeration and air conditioning compressors market in 2017
  
• On the basis of end-use, the refrigeration segment is anticipated to dominate the market in terms of value in the overall refrigeration and air conditioning compressors market
  

Regional Analysis
China and South East Asia & Pacific are estimated to have collectively accounted for more than 3/5^th of the overall value share in the global refrigeration and air conditioning compressors market by the end of 2017. The China refrigeration and air conditioning compressors market is expected to remain dominant over the forecast period. Asia Pacific is a key production base for various products, including consumer appliances (refrigerators, freezers, etc.) and hence, the region is expected to create significant growth opportunities with a relatively high CAGR in the global refrigeration and air conditioning compressors market.
Vendor Insights
The report highlights some of the top companies operating in the global refrigeration and air conditioning compressors market such as Emerson Electric Co., The Danfoss Group, Mitsubishi Electric Corporation, GEA Group AG, Bitzer SE, Frascold S.p.A., Fusheng Co., Ltd., LG Electronics, Inc., Huayi Compressor Co., Ltd., Mayekawa Mfg. Co., Ltd., Panasonic Corporation, Midea Group, Nidec Corporation, Officine Mario Dorin S.p.A., and Tecumseh Products Company LLC.

Know More About Report@ https://www.futuremarketinsights.com/reports/refrigeration-and-air-conditioning-compressors-market

Fiberglass Market Slated to Bring in US$ 13,146.0 Mn by End of 2018-2028

Future Market Insights newly published market report, “Fiberglass (Glass Fiber) Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028,” examines the Fiberglass (Glass Fiber) Market and offers crucial market insights for the next ten years. According to the global fiberglass (glass fiber) market report, the rovings segment by product type is expected to dominate the overall market accounting for over 57% revenue share by 2028-end. The fiberglass (glass fiber) market is expected to register a CAGR of 4.6 % during the forecast period (2018 – 2028). The global fiberglass (glass fiber) market is expected to expand at a CAGR of 4.3 %, accounting for US$ 13,146.0 Mn by the end of 2028.
Global Fiberglass (Glass Fiber) Market Dynamics  
With the growing need for developing walls, doors, windows, and roofs, demand for fiberglass is likely to remain high in the construction industry. Glass fiber is also used as a composite in the construction industry. Manufacturers are utilizing GFRC (glass fiber reinforced concrete), which contains hydrated cement, glass fibers and sand for diverse construction purposes. Incorporation of the fiberglass enables manufacturers to integrate robust features such as anti-corrosiveness, high compressive strength, tensile strength and lightweight. In addition, manufacturers prefer utilizing fiberglass pertaining to the low maintenance cost and erosion. On the account of these factors, growth of the global market is expected to remain positive over the coming years.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5440

Further, growing number of construction projects in various developing countries such as India, Brazil, and China have led manufacturers to invest in fiberglass as an effective insulation component. As fiberglass continues to remain a cheaper alternative for insulation in the construction industry, the global fiberglass (glass fiber) market is likely to witness a significant growth during the forecast period
However, increasing instances of health hazards such as rashes on the skin, irritation in eyes and stomach and soreness in throat and lungs among workers and constructors due to fiberglass have posed challenges to the market growth. As the small glass fibers have the ability to reach the lower parts of internal organs such as stomach, lungs, and skin, risks related to adverse health effects continue to persist. Due to the adverse health effects of fiberglass, manufacturers are looking out for cheaper and safe alternatives. Based on these factors, growth of the global fiberglass (glass fiber) market is likely to face headwinds during the forecast period

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/askus/rep-gb-5440

Major players identified in the fiberglass (glass fiber) market are focusing on increasing their production capacities and acquisition to enhance their operational efficiency, and product portfolio. Also, strategic collaboration and joint venture witnessed among leading market players are likely to improve sales and distribution network. Due to these factors, growth of the global market is expected to gain speedy momentum during the forecast period.
Global Fiberglass (Glass Fiber) Market Forecast
On the basis of glass type segment, the E-class glass type segment is anticipated to be a leading revenue contributor in the fiberglass (glass fiber) market. The segment is estimated to lead the overall fiberglass (glass fiber) market, accounting for an estimated share of almost 86% in terms of volume in 2017. Further, this segment is expected to register a CAGR of 4.1% over the forecast period.
On the basis of regions, China is anticipated to dominate the global fiberglass (glass fiber) market throughout the forecast period in terms of growth. The China fiberglass (glass fiber) market is expected to expand at a CAGR of 5.0 % during the forecast period. Also, the North America fiberglass (glass fiber) market is anticipated to register a CAGR of 4.4% during forecast period. These regions are expected to register the fastest growth in the global fiberglass (glass fiber) market during the forecast period.
Global Fiberglass (Glass Fiber) Market Competitive Landscape
Some of the players identified in the global fiberglass (glass fiber) market are Owens Corning, PFG Fiber Glass Corporation, CPIC Abahsain Fiberglass M.E., W.L.L., Chongqing Polycomp International Corp, and Jushi Group Co., Ltd. among others. Over the recent past, the industry players have focused on acquisitions and increasing their production capacities to meet the growing demand from various end-user industries.

Know More About Report@ https://www.futuremarketinsights.com/reports/fiberglass-market

Hydrofluoric Acid Market to Projected to Touch a Valuation of US$ 4,313.2 Mn End

A new report by Future Market Insights delivers key insights on the global hydrofluoric acid market. The long-term outlook on the global hydrofluoric acid market remains positive, with market value expected to increase at a CAGR of 2.9% during the forecast period (2018-2028). On the basis of grade, the global hydrofluoric acid market is dominated by the anhydrous grade which is typically used for the manufacture of fluorochemicals and accounts for more than 60% of the overall demand for hydrofluoric acid. The aqueous grade or the dilute form of hydrofluoric acid is used for applications such as steel pickling and metal processing industry, rust remover and other such applications and accounts for a relatively smaller share.
Global sales of hydrofluoric acid is estimated to be valued at US$ 4,313.2 Mn by the end of 2018, witnessing a Y-o-Y growth of 2.6% over the year 2017. China is estimated to account for a value share of ~47% in the global hydrofluoric acid market by 2018 end and is anticipated to show significant demand for hydrofluoric acid from the fluorochemicals manufacturing industry.
Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6176
Multiple Applications of Hydrofluoric Acid to Dictate Product Demand During the Forecast Period
The use of hydrofluoric acid as an intermediate for the manufacture of fluorochemicals is by far considered as a relatively larger application area accounting for a share of ~65% in the overall demand. Other applications such as metal processing, steel pickling, metal surface treatment amongst others are projected to expand significantly over the forecast period. Hydrofluoric acid is also widely used in the glass etching process to provide finish and shine to glass surfaces and to improve fuel efficiency in the alkylation process in the petrochemical industry. Another major application of hydrofluoric acid is in the manufacture of aluminium fluoride, which is predominantly used as a raw material for the manufacture of aluminium. There has been an increase in the use of aluminium over the past few years across major end-use industries such as automotive, packaging and other applications. This rise in demand for aluminium will lead to the growth of hydrofluoric acid in the coming years.
However, the global hydrofluoric acid market is projected to face numerous challenges. The raw material largely used for hydrofluoric acid production is fluorspar, which is unevenly distributed with more than 50% of the reserves in China. In order to benefit the local manufacturers, China has restricted the supply of fluorspar to other regions, thus creating significant negative impact on the profitability and margins of global manufacturers.
Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/askus/rep-gb-6176
Hydrofluoric Acid Market: Segmentation Analysis

• On the basis of grade, anhydrous grade is projected to retain its dominance throughout the forecast period holding a share of ~65% by the end of 2018
  
• On the basis of application, the use of Hydrofluoric Acid as starting material or intermediate for the manufacture of fluorochemicals or fluorocarbons is projected to hold major share throughout the forecast period. The rise in demand of such chemicals from refrigeration and air conditioning systems is projected to fuel market revenue growth
  
• There are a number of other application areas for hydrofluoric acid including steel pickling and metal treatment to remove layer and stains from the surface and provide shine and finish to the surface of the material. Other industries such as glass etching, uranium fuel production, petroleum catalyst, pharmaceuticals, herbicides and other niche applications are also projected to drive the demand for hydrofluoric acid over the coming decade
  

Hydrofluoric Acid Market: Regional Analysis
From a regional perspective, China is projected to lead the global market both in terms of production and consumption of hydrofluoric acid. The country has an added advantage of ease of raw material procurement and hence manufacturers are able to offer products at relatively cheaper prices. The growth of end-use industries and the increase in demand for fluorochemicals from refrigeration and air conditioning systems is projected to create significant opportunities in the market. India is also projected to expand at a relatively higher growth rate over the forecast period. Western Europe is considered a relatively mature market with sluggish growth owing to the stringent regulations pertaining to the use of fluorochemicals. Latin America and MEA are projected to hold significant share in terms of production; however, the consumption of hydrofluoric acid is expected to exhibit low volume and high growth during the forecast period.
Know More About Report@ https://www.futuremarketinsights.com/reports/hydrofluoric-acid-market

 

Anti-Caking Agents Market to Incur Meteoric Growth During 2018 - 2028

Market Definition and Introduction
An anti-caking agent is a type of an additive which is added to powdered or granulated materials such as table salt or confectionaries so as to avert the formation of lumps. The formation of lumps is an undesired situation called as caking. The purpose of adding an anti-caking agent to food products is to act as a food additive that keeps powders or granulated materials such as milk powder, powdered sugar, tea and coffee powders used in vending machines, table salt etc. flowing freely. In terms of anti-caking agent applications in animal feed, red lake diatomaceous earth develops the fluidity and mixing abilities of the animal feed. Some anticaking agents are soluble in water, whereas the others are soluble in alcohols or other organic solvents. They either absorb excess moisture or they coat particles and render them water repellant. The commonly used anti-caking agent is calcium silicate, which is used in the food & beverages industry. The right amounts of fertilizer anti-caking agents deliver robust, long-lasting caking control, and are relatively easy to apply to dry fertilizers in a particular operation. These ant-caking agents comprise of ingredients which are suitable for safe use in facilities where they are applied as well as for all downstream uses and applications including agriculture. Thus, anti-caking agents make products practicable for packaging, transport, and for use by end consumer.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6842

Considering these important aspects of applications of anti-caking agents, the study of the anti-caking agents market becomes an important read.
Market Segmentation
On the basis of product type, the anti-caking agents market is segmented as follows:

• Natural anti-caking agents
• Synthetic anti-caking agents

On the basis of end use industry, the anti-caking agents market is segmented as follows:

• Food & Beverages
• Animal Feed
• Fertilizers
• Others

Key Trends, Drivers
Such factors which would positively influence the anti-caking agents demand are expected to drive the market growth to a considerable extent in the near future.
Caking or clumping is a significant concern in dry fertilizer production, storage, transport and application. Crystallization of water soluble salts and the resulting bridges between the surfaces of fertilizer particles is a common mechanism that causes caking. Pressure from storage conditions can also cause the surface of fertilizer particles to experience plastic deformation, causing their new contact surfaces to experience adhesion from reduced water vapor pressure. In the production of dry fertilizers, caking or clumping is an important concern, as well as in the storage, transport and in the end use. The crystallization of water soluble salts and the ensuing bridges formed between the surfaces of fertilizer particles is a mechanism that causes caking. The high pressure resulting from the storage of fertilizers does make the surface of fertilizer particles to experience witness plastic deformation. This causes the new contact surface to experience adhesion as a result of reduced water vapor pressure. It has been observed that high quality anti-caking agents do not undermine the treated fertilizer’s ability to comply with applicable regulatory requirements. Besides, they enhance the treated fertilizer’s marketability, and are economical as well. Such benefits of anti-caking agent applications are expected to fuel the demand for anti-caking agents across different industries, thereby driving the global anti-caking agent market growth in the next few years.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-6842

However, research on anti-caking agents has been hinting that anticaking agents may have an adverse effect on food nutrition. For instance, a specific study result has mentioned that most anti-caking agents resulted in the additional degradation of Vitamin C added to food. Such drawbacks of anti-caking agents have been dampening the growth rate of the anti-caking agents market.
Market Participants
Examples of the market participants in the anti-caking agents market are as follows:

• BASF SE
• Solvay SA
• Kao Group
• PPG Industries, Inc.
• ArrMaz
• R. Grace & Co.-Conn.
• Evonik Industries AG
• JELU-WERK J. Ehrler GmbH & Co. KG
• Allied Blending LP
• EP Minerals
  Know More About Report@ https://www.futuremarketinsights.com/reports/anti-caking-agents-market
  
  
  

Key Insights of Future Prospects of Anti Crystallizing Agents Market During 2018 - 2028

Market Definition and Introduction
Undesired crystallization of products in the food & beverages, pharmaceutical & other industries deteriorates product quality by reducing product texture, taste, whipping properties, flavoring impact, air bubble stability and many other vital product characteristics. Anti crystallizing agents are substances which are added to products especially in the food & beverages industry, to prevent undesired crystallization of foods, beverages, or even water used in processes of these industries. For instance, glucose liquids are a type of anti crystallizing agents. They are obtained by the hydrolysis of starch in which the long-chain carbohydrate molecules are broken down into series of low molecular weight carbohydrates. When spray-dried, they can be used in an even more comprehensive range of anti crystallizing applications. The anti crystallizing property of glucose liquids render them suitable for use in the manufacture of cough syrups, which have  increased viscosity and enhanced mouth feel with no unwarranted escalation of sweetness. In this application, taste masking, as well as tailored rheology and flow properties, all play a vital role in delivery of the pharmaceutical components. The addition of an anti crystallizing agent delays crystal formation which indirectly improves the clarity of the oil or any product to which the agent is added. Besides, the addition of an anti crystallizing agent does not influence the Peroxide Value (PV) of an oil. Furthermore, high quality anti crystallizing agents neither introduce any specific or additional flavor to the main product, nor do they stop slowing down the undesired development & growth of crystals.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6839

Considering these important aspects of applications of anti crystallizing agents, the study of the anti-crystallizing agents market becomes an important read.
Market Segmentation
On the basis of physical form, the anti crystallizing agents market is segmented as follows:

• Solid crystal anti crystallizing agents
• Liquid solution anti crystallizing agents

On the basis of application, the anti crystallizing agents market is segmented as follows:

• Anti crystallizing process for palm oil
• Anti crystallizing process for ice creams
• Anti crystallizing process for sugar
• Other applications

Key Trends, Drivers
Manufacturers of anti crystallizing agents have been focusing on implementing specific branding and marketing strategies to develop a brand image of their anti crystallizing agent products. This has been a part of achieving their strategic objectives to effectively advertise & market the product quality and enhanced features, to gain competitive advantage in an intensely competitive food & beverages industry. This, of course, is apart from their collaborative strategy they adopt with regard to partnering with distributors & suppliers to ensure an effective volume sales, by leveraging the latter’s expertise in specific geographies or product segments. Furthermore, regulatory compliance pertaining to product compositions mandated by national & international food & drug regulatory bodies such as the U.S. Food & Drug Administration (FDA) needs to be met by anti crystallizing agent manufacturers. This in turn, has been increasing the onus on manufacturers, with regard to conforming to legislative statutes.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-6839

Major research & development investments for new anti crystallizing agent product development, however, have been a prerogative of the large, financially sound manufacturers. For instance, the development of modified poly glycerol esters (PGEs) is an example. PGEs have demonstrated that crystal phase properties that are more conducive to the formation of very stable gel network structures, translate into substantially high performance as an anti crystallizing agent in the vegetable oil, biodiesel and oleo chemical industries. Also, manufacturers have been providing consultation in the form of recommended application methods with regard to use of anti crystallizing agents, for augmenting customer satisfaction. These factors are expected to drive the market growth of the anti crystallizing agent market, at a worldwide level.
 Market Participants
Examples of the market participants in the anti crystallizing agents market are as follows:

• Cargill, Incorporated
• I. Famar S.A.
• Nikko Chemicals Co., Ltd.
• Global Specialty Ingredients (M) Sdn Bhd
• Shandong Futaste Co.
• Star Chem FZE
• Roquette
• D. Navkar Bio-chem Private Limited
• Fine Organics
• BMSG
  Know More About Report@ https://www.futuremarketinsights.com/reports/anti-crystallizing-agents-market
  
  
  

Automotive Carbon Ceramic Brakes Market to Projected to Touch a Valuation of US$ 400 Mn by 2026-End

Compared to cast iron discs, carbon ceramic bikes might be four times costlier, but that hasn't side-tracked automobile manufacturers from using them to increase the USP of their automotive offerings. Performance of vehicles equipped with automotive carbon ceramic brakes is getting boosted, making these brakes a must-have for high-performance cars. A latest study published by Future Market Insights projects that the global market for automotive carbon ceramic brakes will witness an outright dominance of passenger car vehicles in the years to come. Apropos the report, over 99% of the global automotive carbon ceramic brakes revenues will be accounted by passenger cars.
Future Market Insights’ report predicts that the demand for automotive carbon ceramic brakes is gaining traction in production of luxury vehicles. Moreover, enhancements such as lightweight rotors, noise control, and non-corroding brake pads are also prompting the sales of automotive carbon ceramic brakes across the globe. Presently, the global market for automotive carbon ceramic brakes is estimated to be valued at US$ 265 Mn. Towards the end of 2026, the market is anticipated to showcase revenue growth at 10.3% CAGR and bring in more than US$ 700 Mn in revenues. Companies such as Brembo SGL Carbon Ceramic Brakes, Surface Transforms Plc., Rotora Inc., Fusion Brakes LLC, Carbon Ceramics Ltd., and Akebono Brake Industry Co. Ltd. are observed to be leading manufacturers of automotive carbon ceramic brakes in the world.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1519

In the report, titled “Automotive Carbon Ceramic Brakes Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” growth of the global automotive carbon ceramic brakes market will be contingent upon following factors:

• Higher adoption of iron casts brakes, which are cheaper than automotive carbon ceramic brakes
  
• Automotive carbon ceramic brakes lacking compatibility at high operating temperatures
  
• Rising preference to lightweight brakes such as automotive carbon ceramic brakes in order to lower gross weight of vehicles and hike their performance level
  
• Stringent emission norms across several regions, that promote the use of lightweight automotive carbon ceramic brakes
  
• Higher disposable incomes, which are propelling the sales of luxury and sports cars that come equipped with automotive carbon ceramic brakes
  
• Proliferating trend of vehicle customisation, witnessed in multiple regions
  
  Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/askus/rep-gb-1519

The report further reveals that by the end of 2026, close to 90% of global automotive carbon ceramic brake sales will be accounted by OEMs. On the other hand, revenues arising from aftermarket sales channels will gain traction towards the latter half of forecast period, registering more than 11% CAGRs in terms of volume as well as value. In 2016, sales of more than 47,000 units of automotive carbon ceramic brakes were recorded across Canada and the US. While North America registers fastest revenue growth, the largest market for automotive carbon ceramic brakes continues to be Western Europe. By 2026, the automotive carbon ceramic brakes market in Western Europe is projected to surpass US$ 300 Mn value.

Know More About Report@ https://www.futuremarketinsights.com/reports/automotive-carbon-ceramic-brakes-market

Solar Charge Controller Market: Introduction
A solar charge controller is a stand-alone device, basically a current or voltage regulator, which helps in managing the power received in the battery bank from a solar array. The charge controller ensures and protects deep cycle batteries from being overcharged by the solar modules during the day time and prevents reverse flow by the loads during the night time. Overcharging of batteries is capable of affecting the life span of batteries negatively and may even cause damage to the performance of the battery. Hence, a solar charge controller plays an important role in a solar power distribution system. Growing installation of solar plants due to their zero impact on the environment is creating significant opportunities for solar charge controller manufacturers. Owing to their various salient features, the global market for solar charge controllers is expected to witness significant growth during the forecast period.
Solar Charge Controller Market: Dynamics
Depletion of non-renewable resources of energy is leading to growing demand for renewable resources of energy, including solar energy. This is one of the key factors driving the demand for solar charge controllers. According to the International Energy Agency, in 2016, the solar energy industry was the fastest growing source of new energy across the globe. Urgent need for reduction in the dependency on fossil fuels is leading to several initiatives being implemented by governments across the globe, encouraging the use of renewable resources, which, in turn, is driving the demand for solar energy. This will propel the demand for solar charge controllers across the globe.

Request For Report Sample@  https://www.futuremarketinsights.com/reports/sample/rep-gb-6305

Increasing demand for MPPT (maximum power point tracking) type charge controllers is an on-going trend gaining momentum in the solar charge controller market. MPPT type solar charge controllers are the preferred choice for higher power systems due to their lower overall system cost. PWM type solar charge controllers, on the other hand, are suitable for smaller systems with moderate to high temperature range.
Solar Charge Controller Market: Segment
The global solar charge controller market can be segmented on the basis of battery type, working type and current carrying capacity
By battery type, the global solar charge controller market can be segmented into:

• Lead-Acid/AGM/Gel battery
• Lithium battery

By working type, the global solar charge controller market can be segmented into:

• PWM (Pulse Width Modulation)
• MPPT (Maximum Power Point Tracking)
• Simple 1 or 2 stage controls

By current carrying capacity, the global solar charge controller market can be segmented into:

• Less than 8A
• 8 A to 20A
• 20A to 30A
• More than 30A

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-6305

Solar Charge Controller Market: Regional Outlook
Ecofriendly features related to solar energy generation will force the global market of solar charge controllers to grow at a rapid pace during the forecast period. Several vital features, such as protecting the battery from over charging, high reliability, monitoring the reverse current, providing auto charge indication, etc. are expected to contribute to the growth of solar charge controller market across the globe. Increasing installation of solar plants in different countries of the Asia Pacific region is expected to propel the demand for solar charge controllers in the region. In 2016, China accounted for almost half of the solar panels installed across the globe. Solar power in India is also a fast developing industry. As of October 2017, the country had a cumulative capacity of 15.6 GW. Following the renewable energy trend across the globe, the Egyptian government has also initiated investments for solar and wind energy plants, which, in turn, is expected to boost the demand for solar charge controller in the region over the coming years. The U.S. is the second fastest growing country in the renewable energy sector and has reached 49.3 GW in total installed capacity.
Solar Charge Controller Market: Key Participants
Examples of some of the market participants identified across the value chain of the global solar charge controller market include:

• Genasun LLC
• Luminous India
• Studer Innotec
• Steca Elektronik GmbH
• Samlex America, Inc
• Shenzhen Shuori New Energy Technology Co.,Ltd.
• Phocos
• BEIJING EPSOLAR TECHNOLOGY CO.,LTD

Know More About Report@ https://www.futuremarketinsights.com/reports/solar-charge-controller-market